about
Evommune Inc is a clinical-stage biotechnology company focused on creating new therapies aimed at key factors driving chronic inflammatory diseases. The initial clinical programs of the company target chronic spontaneous urticaria (CSU), atopic derma...
Read More
13.21
-0.30
(-2.22%)
585.9K
XNYS Volume
XNYS 10 Jul, 2026 5:30 PM (EDT)
Not Eligible
Expensive Valuation
Technically Bearish
Evommune Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..